TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.

Daneshmand S, Van der Heijden MS, Jacob JM, Guerrero-Ramos F, Bögemann M, Simone G, Pieczonka CM, Casco NC, Zainfeld D, Spiegelhalder P, Xylinas E, Cahn D, Lotan Y, Murray KS, Kawahara T, Stromberg K, Martin J, Shukla A, Cutie CJ, Bertzos K, Hampras S, Sweiti H, Necchi A, SunRISe-1 Study

Open source

DOI: 10.1200/jco-25-01651
Published: 2025 Nov 20
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-01651,
  title = {TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.},
  author = {Daneshmand S and Van der Heijden MS and Jacob JM and Guerrero-Ramos F and Bögemann M and Simone G and Pieczonka CM and Casco NC and Zainfeld D and Spiegelhalder P and Xylinas E and Cahn D and Lotan Y and Murray KS and Kawahara T and Stromberg K and Martin J and Shukla A and Cutie CJ and Bertzos K and Hampras S and Sweiti H and Necchi A and SunRISe-1 Study},
  year = {2025},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-01651},
  url = {https://doi.org/10.1200/jco-25-01651}
}

RIS

TY  - JOUR
TI  - TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.
AU  - Daneshmand S
AU  - Van der Heijden MS
AU  - Jacob JM
AU  - Guerrero-Ramos F
AU  - Bögemann M
AU  - Simone G
AU  - Pieczonka CM
AU  - Casco NC
AU  - Zainfeld D
AU  - Spiegelhalder P
AU  - Xylinas E
AU  - Cahn D
AU  - Lotan Y
AU  - Murray KS
AU  - Kawahara T
AU  - Stromberg K
AU  - Martin J
AU  - Shukla A
AU  - Cutie CJ
AU  - Bertzos K
AU  - Hampras S
AU  - Sweiti H
AU  - Necchi A
AU  - SunRISe-1 Study
PY  - 2025
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-01651
UR  - https://doi.org/10.1200/jco-25-01651
ER  -

APA

S, D., MS, V. D. H., JM, J., F, G., M, B., G, S., CM, P., NC, C., D, Z., P, S., E, X., D, C., Y, L., KS, M., T, K., K, S., J, M., A, S., CJ, C., K, B., S, H., H, S., A, N., & Study, S. (2025). TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-01651

Source records

pubmed · retrieved 2026-09-25T19:36:18.704Z